26
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Suggestions for infection prevention and control in digestive endoscopy during current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Up to 4 February 2020, over 20 000 laboratory-confirmed cases of novel coronavirus (2019-nCoV) infection have been reported in China, of which more than 60 % are in Wuhan city and Hubei province. Patients may display a wide range of symptoms, while others are asymptomatic or have minimal symptoms after becoming infected 1 2 . Although fever, fatigue, and dry cough are the most common symptoms, diarrhea has been observed as the first symptom in many young patients, while abdominal discomfort and poor appetite are shown in elderly patients. Our data have shown that more than 50 % of patients with confirmed or suspected infection present with diarrhea (16/28). The transmission rate indicated by reproductive number (Ro) is 4.08 according to a recent study 3 . The total mortality rate of 2019-nCoV pneumonia is only 2 %, according to the analysis of public data. However, the mortality rate of severe cases of 2019-nCoV pneumonia has been between 10 % and 40 % on different days of the outbreak in Wuhan. As the Chinese Spring Festival holiday comes to an end, most endoscopy centers in China will reopen to patients who need endoscopic operations. 2019-nCoV has been described to be transmitted from respiratory secretions, feces, and contaminated environmental surfaces 1 4 . In addition, the virus is spread not only by patients with symptoms but also by asymptomatic individuals 2 . Due to the inevitable exposure to respiratory secretions during upper gastrointestinal (GI) endoscopy and exposure to feces during colonoscopy, all individuals in the endoscopy center are at high risk of exposure to the virus, especially the staff in the operating room. To prevent 2019-nCoV transmission in the endoscopy center, we offer the following summary and recommendations for infection prevention and control in digestive endoscopy during the current outbreak of 2019-nCoV according to the epidemiological characteristics we have observed, combined with past experience and the literature ( Fig. 1 ) Fig. 1  Diagnosis and treatment workflow in a gastrointestinal endoscopy center during the 2019-nCoV outbreak. CT, computed tomography; GI, gastrointestinal. Endoscopy in outbreak areas In outbreak areas such as Hubei province, only emergency endoscopy should be performed to treat patients with diseases such as acute GI bleeding, foreign bodies in the GI tract, and acute suppurative cholangitis. In the epidemic area, after the screening process, the basic protection requirements of the medical staff in the endoscopy center should achieve biosafety level 2 for all GI endoscopic procedures 5 6 . Protection at biosafety level 3 is required for all endoscopic procedures in patients with confirmed or suspected 2019-nCoV infection, and for those with very high risk of potential exposure to 2019-nCoV, such as during tracheal intubation, airway care, and sputum suction in noninfected patients 5 6 . Endoscopy in other areas of China In other areas of China, routine endoscopy should be performed with extra precautions to avoid hospital transmission from those patients with 2019-nCoV infection. Identification of patients with potential 2019-nCoV infection is the first critical step in prevention and infection control. Chest computed tomography (CT) is the most reliable approach based on our experiences, as some patients have no clinical manifestations or display only slight digestive tract symptoms; CT scans can reveal interstitial pneumonia in the outer zone of one or both lungs. Moreover, we found that CT manifestations may appear earlier than nucleic acid detection, and in a few patients with epidemiological history, typical chest CT manifestations, and typical clinical outcome of 2019-nCov pneumonia, the viral pneumonia etiologies in the local region – including 2019-nCov etiology detection – are all negative. Therefore, we believe that CT examination of the lung is faster and more effective than etiological examination for screening of 2019 nCov pneumonia. Compared with other kinds of viral pneumonia, the family aggregation of 2019-nCov pneumonia is more obvious. The following workflow is recommended for all endoscopy centers in China based on the current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China. Staff protection Ensuring that staff are working in a safe and clean environment is a critical step. The following approaches are recommended to prevent staff from transmitting 2019-nCoV in the endoscopy center. Any member of staff showing fever, fatigue, and dry cough, or who has had contact with a 2019-nCoV-infected patient should be identified and treated appropriately. Compulsory temperature checks should be performed for everyone every day before entering the work area. Hand hygiene: staff are required to wash their hands following the “six-step hand-washing method” or to clean hands with quick-drying hand sanitizer for 2 minutes. Protection at biosafety level 2 is required for staff who are in direct contact with patients, such as wearing disposable gowns, N95 masks, goggles, caps, and shoe covers during the operation. Protection at biosafety level 3 is required when performing tracheal intubation, airway care, and sputum suction in patients without 2019-nCoV. Protection at biosafety level 3 is required when performing all endoscopic procedures in patients with confirmed or suspected 2019-nCoV infection. The examination report could be completed by other qualified staff in the clean area and supervised by a doctor from the operation area; this could avoid the potential for contamination. Post-procedure, staff are required to remove all protective clothing and gear and to clean their hands before entering the rest area. All protective gear should be disposed of properly. The general medical mask is required in all areas. When off duty, staff are required to stay at home as much as possible. Disinfection management As coronavirus, including 2019-nCoV, is inactivated by many commonly used disinfectants, no additional measures are necessary for endoscope cleaning and disinfection 7 8 9 10 . For the endoscopy center environment, UV irradiation and ozone treatment are recommended for the cleaning and sterilization of air and all surfaces, such as endoscopic equipment, office tables, and walls of the examination room. Chlorine-containing detergent is recommended for daily floor cleaning 8 9 . In general, we suggest that endoscopy examination and procedures should be strictly limited in all areas of China during the current outbreak in order to combat against 2019-nCoV. For essential endoscopy procedures, pre-screening of patients and protection of staff are critical to avoid hospital transmission.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

          Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            First Case of 2019 Novel Coronavirus in the United States

            Summary An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient’s initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

              To the Editor: The novel coronavirus (2019-nCoV) from Wuhan is currently causing concern in the medical community as the virus is spreading around the world. 1 Since identification of the virus in late December 2019, the number of cases from China that have been imported into other countries is on the rise, and the epidemiologic picture is changing on a daily basis. We are reporting a case of 2019-nCoV infection acquired outside Asia in which transmission appears to have occurred during the incubation period in the index patient. A 33-year-old otherwise healthy German businessman (Patient 1) became ill with a sore throat, chills, and myalgias on January 24, 2020. The following day, a fever of 39.1°C (102.4°F) developed, along with a productive cough. By the evening of the next day, he started feeling better and went back to work on January 27. Before the onset of symptoms, he had attended meetings with a Chinese business partner at his company near Munich on January 20 and 21. The business partner, a Shanghai resident, had visited Germany between January 19 and 22. During her stay, she had been well with no signs or symptoms of infection but had become ill on her flight back to China, where she tested positive for 2019-nCoV on January 26 (index patient in Figure 1) (see Supplementary Appendix, available at NEJM.org, for details on the timeline of symptom development leading to hospitalization). On January 27, she informed the company about her illness. Contact tracing was started, and the above-mentioned colleague was sent to the Division of Infectious Diseases and Tropical Medicine in Munich for further assessment. At presentation, he was afebrile and well. He reported no previous or chronic illnesses and had no history of foreign travel within 14 days before the onset of symptoms. Two nasopharyngeal swabs and one sputum sample were obtained and were found to be positive for 2019-nCoV on quantitative reverse-transcriptase–polymerase-chain-reaction (qRT-PCR) assay. 2 Follow-up qRT-PCR assay revealed a high viral load of 108 copies per milliliter in his sputum during the following days, with the last available result on January 29. On January 28, three additional employees at the company tested positive for 2019-nCoV (Patients 2 through 4 in Figure 1). Of these patients, only Patient 2 had contact with the index patient; the other two patients had contact only with Patient 1. In accordance with the health authorities, all the patients with confirmed 2019-nCoV infection were admitted to a Munich infectious diseases unit for clinical monitoring and isolation. So far, none of the four confirmed patients show signs of severe clinical illness. This case of 2019-nCoV infection was diagnosed in Germany and transmitted outside Asia. However, it is notable that the infection appears to have been transmitted during the incubation period of the index patient, in whom the illness was brief and nonspecific. 3 The fact that asymptomatic persons are potential sources of 2019-nCoV infection may warrant a reassessment of transmission dynamics of the current outbreak. In this context, the detection of 2019-nCoV and a high sputum viral load in a convalescent patient (Patient 1) arouse concern about prolonged shedding of 2019-nCoV after recovery. Yet, the viability of 2019-nCoV detected on qRT-PCR in this patient remains to be proved by means of viral culture. Despite these concerns, all four patients who were seen in Munich have had mild cases and were hospitalized primarily for public health purposes. Since hospital capacities are limited — in particular, given the concurrent peak of the influenza season in the northern hemisphere — research is needed to determine whether such patients can be treated with appropriate guidance and oversight outside the hospital.
                Bookmark

                Author and article information

                Journal
                Endoscopy
                Endoscopy
                10.1055/s-00000012
                Endoscopy
                © Georg Thieme Verlag KG (Stuttgart · New York )
                0013-726X
                1438-8812
                April 2020
                25 March 2020
                : 52
                : 4
                : 312-314
                Affiliations
                [1 ]Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
                [2 ]Clinical Center and Key Lab of Intestinal and Colorectal Diseases of Hubei Province, Wuhan, China
                Author notes
                Corresponding author Qiu Zhao, MD Department of Gastroenterology Zhongnan Hospital of Wuhan University 169 Donghu RoadWuhan 430071, HubeiChina+86-27-67812522 qiuzhao@ 123456whu.edu.cn
                Article
                10.1055/a-1128-4313
                7117069
                32212122
                63bd3961-5b64-42ff-bf20-95a523dd5c14
                Copyright @ 2020

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Categories
                Letter to the editor

                Comments

                Comment on this article